| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | Common Stock | +Options Exercise | $618,624 | +3,394 | +12.02% | $182.27 | 31,628 | Mar 1, 2023 | Direct | F1 |
| transaction | AVY | Common Stock | -Tax liability | -$164,590 | -903 | -2.86% | $182.27 | 30,725 | Mar 1, 2023 | Direct | |
| transaction | AVY | Common Stock | +Options Exercise | $170,605 | +936 | +3.05% | $182.27 | 31,661 | Mar 1, 2023 | Direct | F2 |
| transaction | AVY | Common Stock | -Tax liability | -$45,750 | -251 | -0.79% | $182.27 | 31,410 | Mar 1, 2023 | Direct | |
| transaction | AVY | Common Stock | +Options Exercise | $152,560 | +837 | +2.66% | $182.27 | 32,247 | Mar 1, 2023 | Direct | F3 |
| transaction | AVY | Common Stock | -Tax liability | -$37,183 | -204 | -0.63% | $182.27 | 32,043 | Mar 1, 2023 | Direct | |
| transaction | AVY | Common Stock | +Options Exercise | $62,701 | +344 | +1.07% | $182.27 | 32,387 | Mar 1, 2023 | Direct | F4 |
| transaction | AVY | Common Stock | -Tax liability | -$15,311 | -84 | -0.26% | $182.27 | 32,303 | Mar 1, 2023 | Direct | |
| transaction | AVY | Common Stock | +Options Exercise | $79,287 | +435 | +1.35% | $182.27 | 32,738 | Mar 1, 2023 | Direct | F5 |
| transaction | AVY | Common Stock | -Tax liability | -$19,321 | -106 | -0.32% | $182.27 | 32,632 | Mar 1, 2023 | Direct | |
| holding | AVY | Common Stock (Savings Plan) | 2,466 | Mar 1, 2023 | Savings Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVY | 2023 MSU Award | +Grant/Award | $0 | +1,318 | $0.00 | 1,318 | Mar 1, 2023 | Common Stock | 1,318 | $0.00 | Direct | F6 | |
| transaction | AVY | 2023 PU Award | +Grant/Award | $0 | +1,359 | $0.00 | 1,359 | Mar 1, 2023 | Common Stock | 1,359 | $0.00 | Direct | F7 | |
| transaction | AVY | 2020 PU Award | -Options Exercise | $0 | -3,394 | -100% | $0.00 | 0 | Mar 1, 2023 | Common Stock | 3,394 | $0.00 | Direct | F1 |
| transaction | AVY | 2019 MSU Award | -Options Exercise | $0 | -936 | -100% | $0.00 | 0 | Mar 1, 2023 | Common Stock | 936 | $0.00 | Direct | F2 |
| transaction | AVY | 2020 MSU Award | -Options Exercise | $0 | -837 | -63.22% | $0.00 | 487 | Mar 1, 2023 | Common Stock | 837 | $0.00 | Direct | F3 |
| transaction | AVY | 2021 MSU Award | -Options Exercise | $0 | -344 | -38.31% | $0.00 | 554 | Mar 1, 2023 | Common Stock | 344 | $0.00 | Direct | F4 |
| transaction | AVY | 2022 MSU Award | -Options Exercise | $0 | -435 | -23.36% | $0.00 | 1,427 | Mar 1, 2023 | Common Stock | 435 | $0.00 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Shares reflect the vesting of performance units granted in February 2020 at 200% of target, 50% based on our cumulative economic value added and 50% on our relative total stockholder return. |
| F2 | Shares reflect the vesting of the fourth tranche of market-leveraged stock units granted in February 2019 at 200% of target based on our absolute total stockholder return in excess of 10% during the 2019-2022 performance period, plus dividend equivalents accrued during the period. |
| F3 | Shares reflect the vesting of the third tranche of market-leveraged stock units granted in February 2020 at 164% of target based on our absolute total stockholder return in excess of 10% during the 2020-2022 performance period, plus dividend equivalents accrued during the period. |
| F4 | Shares reflect the vesting of the second tranche of market-leveraged stock units granted in February 2021 at 121% of target based on our absolute total stockholder return in excess of 10% during the 2021-2022 performance period, plus dividend equivalents accrued during the period. |
| F5 | Shares reflect the vesting of the first tranche of market-leveraged stock units granted in February 2022 at 90% of target based on our absolute total stockholder return in excess of 10% during the 2022 performance period, plus dividend equivalents accrued during the period. |
| F6 | Market-leveraged stock units vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on the percentage change in the Company's stock price, plus dividend equivalents accrued during the vesting period. Each market-leveraged stock unit represents a contingent right to receive one share of common stock, plus accrued dividend equivalents. |
| F7 | Performance units vest, if at all, at the end of fiscal year 2025, provided certain performance objectives are met as determined by the Compensation Committee in February 2026. Each performance unit represents a contingent right to receive one share of common stock |